Zum Seiteninhalt springen

The application deadline is July 4th, 2022 (14:00 CET).


SPARK-BIH supports the development of novel therapeutics, medical devices and diagnostics, as well as the repurposing of existing drugs for new indications. Translational research projects can come from any medical field. SPARK-BIH empowers project teams to overcome translational hurdles through funding, education, mentoring, expert advice, and entrepreneurship support. Why not let the SPARK-BIH program support you in enhancing the translatability of your innovative project for the benefit of patients.


Exclusively, scientists and clinicians from BIH and Charité are eligible to apply for funding. The number of project proposals per applicant is not limited.

For more information, please visit the SPARK Website.